drugset / Trial / NCT00004802
Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dichlorphenamide for Periodic Paralyses and Associated Sodium Channel Disorders
Phase 3
Completed
64 enrolled
National Center for Research Resources (NCRR)
Ohio State University · collab
RandomizedDouble-blindTreatment
Summary
OBJECTIVES: I. Assess the efficacy of dichlorphenamide in the treatment of episodic weakness attacks in patients with hyperkalemic periodic paralysis, paramyotonia congenita with periodic paralysis, and hypokalemic periodic paralysis.
Timeline
- Start
- 1992-06
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dichlorphenamide | Small molecule | — | Oral |